Immuneering Corporation

IMRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$36,145$59,406$72,637$74,888
Short-Term Investments$0$26,260$32,888$74,311
Receivables$0$0$12$246
Inventory$0$0$0$0
Other Curr. Assets$3,443$3,418$3,210$2,889
Total Curr. Assets$39,588$89,084$108,747$152,334
Property Plant & Equip (Net)$4,790$5,396$5,777$6,131
Goodwill$6,690$6,690$6,690$6,702
Intangibles$350$380$409$439
Long-Term Investments$0$0$0$997
Tax Assets$0$0$0$0
Other NC Assets$1,296$1,034$744$102
Total NC Assets$13,127$13,501$13,620$14,371
Other Assets$0$0$0$0
Total Assets$52,714$102,585$122,367$166,705
Liabilities
Payables$1,959$2,112$3,155$1,394
Short-Term Debt$338$300$379$274
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,207$5,434$4,521$3,965
Total Curr. Liab.$7,504$7,846$8,054$5,634
LT Debt$3,824$4,163$4,463$5,091
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,824$4,163$4,463$5,091
Other Liabilities$0$0$0$0
Cap. Leases$4,163$4,463$4,842$5,365
Total Liabilities$11,328$12,008$12,517$10,725
Equity
Pref Stock$0$0$0$0
Common Stock$31$29$26$26
Retained Earnings-$224,295-$163,259-$109,787-$59,273
AOCI$0-$1-$30-$49
Other Equity$265,650$253,806$219,641$215,276
Total Equity$41,386$90,576$109,850$155,980
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$52,714$102,585$122,367$166,705
Net Debt-$31,982-$54,943-$67,795-$69,523